Trading pharma: 5 plays on Bristol's rough day By: CNBC.com News May 29, 2015 at 18:47 PM EDT Bristol-Myers Squibb's battering after a disappointing drug trial serves as a buying opportunity, "Fast Money" traders said. Read More >> Related Stocks: Bristol-Myers Squibb Eli Lilly Pfizer